Diagnosed with cancer, a pharma exec transformed drug development

Kathy Giusti became a patient advocate after being diagnosed with multiple myeloma at age 37. 

September 3, 2024 Check out STAT+

Sponsored By

Christopher Capozziello for STAT STAT+ | Diagnosed with cancer, a pharmaceutical executive became a patient advocate and changed drug development. It took decades STAT profiles Kathy Giusti, cancer survivor, author of "Fatal to Fearless," and former pharma exec who raised $600 million for multiple myeloma research. By Matthew Herper A STAT Investigation: Embedded Bias In today's health and life science news, a profile of Kathy Giusti and the start of a major investigation of the race-based algorithms in medicine. By Theresa Gaffney STAT+ | European court sides with Illumina, saying regulators overstepped in scrutiny of Grail deal Illumina has already divested Grail, but it will no longer have to pay a major fine as a result of the court ruling. By Andrew Joseph

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser